Related Experiment Video
Updated: Mar 2, 2026
06:38
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
14.3K
Setting Research Priorities for Kidney Cancer
Jennifer M Jones1, Jaimin Bhatt2, Jonathan Avery3
1Cancer Rehabilitation and Survivorship Program, Princess Margaret Cancer Centre, University Health Network, and Department of Psychiatry, University of Toronto, Toronto, Canada.
European Urology
|May 13, 2017
Summary
Establishing kidney cancer research priorities involves patients and clinicians to guide resource allocation. This collaborative approach identified ten key areas for advancing kidney cancer management and knowledge.
Area of Science:
- Oncology
- Health Services Research
Background:
- Limited resources necessitate defined research priorities in cancer.
- Patient and caregiver involvement enhances the value of priority-setting processes.
- Kidney cancer research requires a structured approach to identify critical areas.
Discussion:
- A collaborative consensus-based partnership was established for kidney cancer research.
- The Kidney Cancer Research Network of Canada sponsored this initiative.
- Ten key research priorities in kidney cancer management were identified.
Key Insights:
- Collaborative priority-setting is valuable for kidney cancer research.
- Identified priorities address critical gaps in current knowledge and initiatives.
- Patient and clinician input is crucial for defining research agendas.
Outlook:
- The identified priorities will guide future kidney cancer research funding and efforts.
- Further investigation into these ten priorities is recommended.
- This model can be applied to other cancer types for resource optimization.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
397
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
397
01:28Chronic Kidney Disease III: Interprofessional Care
539
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
539
01:28Kidney Transplant I: Introduction
599
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
599
01:28Imaging Studies I: Kidney, Ureter, and Bladder Studies
489
Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
489
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:25Chronic Kidney Disease I: Introduction
872
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
872